Serum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis

Abstract Atherosclerosis has been considered as the main cause of morbidity, mortality, and disability worldwide. The first screening for antigen markers was conducted using the serological identification of antigens by recombinant cDNA expression cloning, which has identified adaptor-related protei...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shu-Yang Li, Yoichi Yoshida, Eiichi Kobayashi, Masaaki Kubota, Tomoo Matsutani, Seiichiro Mine, Toshio Machida, Yoshiro Maezawa, Minoru Takemoto, Koutaro Yokote, Yoshio Kobayashi, Hirotaka Takizawa, Mizuki Sata, Kazumasa Yamagishi, Hiroyasu Iso, Norie Sawada, Shoichiro Tsugane, Sohei Kobayashi, Kazuyuki Matsushita, Fumio Nomura, Hisahiro Matsubara, Makoto Sumazaki, Masaaki Ito, Satoshi Yajima, Hideaki Shimada, Katsuro Iwase, Hiromi Ashino, Hao Wang, Kenichiro Goto, Go Tomiyoshi, Natsuko Shinmen, Rika Nakamura, Hideyuki Kuroda, Yasuo Iwadate, Takaki Hiwasa
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/407d11808bd449c58f058a7e82ba8eb4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:407d11808bd449c58f058a7e82ba8eb4
record_format dspace
spelling oai:doaj.org-article:407d11808bd449c58f058a7e82ba8eb42021-12-02T14:33:57ZSerum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis10.1038/s41598-021-92786-92045-2322https://doaj.org/article/407d11808bd449c58f058a7e82ba8eb42021-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-92786-9https://doaj.org/toc/2045-2322Abstract Atherosclerosis has been considered as the main cause of morbidity, mortality, and disability worldwide. The first screening for antigen markers was conducted using the serological identification of antigens by recombinant cDNA expression cloning, which has identified adaptor-related protein complex 3 subunit delta 1 (AP3D1) as an antigen recognized by serum IgG antibodies of patients with atherosclerosis. Serum antibody levels were examined using the amplified luminescent proximity homogeneous assay-linked immunosorbent assay (AlphaLISA) using a recombinant protein as an antigen. It was determined that the serum antibody levels against AP3D1 were higher in patients with acute ischemic stroke (AIS), transient ischemic attack, diabetes mellitus (DM), cardiovascular disease, chronic kidney disease (CKD), esophageal squamous cell carcinoma (ESCC), and colorectal carcinoma than those in the healthy donors. The area under the curve values of DM, nephrosclerosis type of CKD, and ESCC calculated using receiver operating characteristic curve analysis were higher than those of other diseases. Correlation analysis showed that the anti-AP3D1 antibody levels were highly associated with maximum intima-media thickness, which indicates that this marker reflected the development of atherosclerosis. The results of the Japan Public Health Center-based Prospective Study indicated that this antibody marker is deemed useful as risk factors for AIS.Shu-Yang LiYoichi YoshidaEiichi KobayashiMasaaki KubotaTomoo MatsutaniSeiichiro MineToshio MachidaYoshiro MaezawaMinoru TakemotoKoutaro YokoteYoshio KobayashiHirotaka TakizawaMizuki SataKazumasa YamagishiHiroyasu IsoNorie SawadaShoichiro TsuganeSohei KobayashiKazuyuki MatsushitaFumio NomuraHisahiro MatsubaraMakoto SumazakiMasaaki ItoSatoshi YajimaHideaki ShimadaKatsuro IwaseHiromi AshinoHao WangKenichiro GotoGo TomiyoshiNatsuko ShinmenRika NakamuraHideyuki KurodaYasuo IwadateTakaki HiwasaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-15 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Shu-Yang Li
Yoichi Yoshida
Eiichi Kobayashi
Masaaki Kubota
Tomoo Matsutani
Seiichiro Mine
Toshio Machida
Yoshiro Maezawa
Minoru Takemoto
Koutaro Yokote
Yoshio Kobayashi
Hirotaka Takizawa
Mizuki Sata
Kazumasa Yamagishi
Hiroyasu Iso
Norie Sawada
Shoichiro Tsugane
Sohei Kobayashi
Kazuyuki Matsushita
Fumio Nomura
Hisahiro Matsubara
Makoto Sumazaki
Masaaki Ito
Satoshi Yajima
Hideaki Shimada
Katsuro Iwase
Hiromi Ashino
Hao Wang
Kenichiro Goto
Go Tomiyoshi
Natsuko Shinmen
Rika Nakamura
Hideyuki Kuroda
Yasuo Iwadate
Takaki Hiwasa
Serum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis
description Abstract Atherosclerosis has been considered as the main cause of morbidity, mortality, and disability worldwide. The first screening for antigen markers was conducted using the serological identification of antigens by recombinant cDNA expression cloning, which has identified adaptor-related protein complex 3 subunit delta 1 (AP3D1) as an antigen recognized by serum IgG antibodies of patients with atherosclerosis. Serum antibody levels were examined using the amplified luminescent proximity homogeneous assay-linked immunosorbent assay (AlphaLISA) using a recombinant protein as an antigen. It was determined that the serum antibody levels against AP3D1 were higher in patients with acute ischemic stroke (AIS), transient ischemic attack, diabetes mellitus (DM), cardiovascular disease, chronic kidney disease (CKD), esophageal squamous cell carcinoma (ESCC), and colorectal carcinoma than those in the healthy donors. The area under the curve values of DM, nephrosclerosis type of CKD, and ESCC calculated using receiver operating characteristic curve analysis were higher than those of other diseases. Correlation analysis showed that the anti-AP3D1 antibody levels were highly associated with maximum intima-media thickness, which indicates that this marker reflected the development of atherosclerosis. The results of the Japan Public Health Center-based Prospective Study indicated that this antibody marker is deemed useful as risk factors for AIS.
format article
author Shu-Yang Li
Yoichi Yoshida
Eiichi Kobayashi
Masaaki Kubota
Tomoo Matsutani
Seiichiro Mine
Toshio Machida
Yoshiro Maezawa
Minoru Takemoto
Koutaro Yokote
Yoshio Kobayashi
Hirotaka Takizawa
Mizuki Sata
Kazumasa Yamagishi
Hiroyasu Iso
Norie Sawada
Shoichiro Tsugane
Sohei Kobayashi
Kazuyuki Matsushita
Fumio Nomura
Hisahiro Matsubara
Makoto Sumazaki
Masaaki Ito
Satoshi Yajima
Hideaki Shimada
Katsuro Iwase
Hiromi Ashino
Hao Wang
Kenichiro Goto
Go Tomiyoshi
Natsuko Shinmen
Rika Nakamura
Hideyuki Kuroda
Yasuo Iwadate
Takaki Hiwasa
author_facet Shu-Yang Li
Yoichi Yoshida
Eiichi Kobayashi
Masaaki Kubota
Tomoo Matsutani
Seiichiro Mine
Toshio Machida
Yoshiro Maezawa
Minoru Takemoto
Koutaro Yokote
Yoshio Kobayashi
Hirotaka Takizawa
Mizuki Sata
Kazumasa Yamagishi
Hiroyasu Iso
Norie Sawada
Shoichiro Tsugane
Sohei Kobayashi
Kazuyuki Matsushita
Fumio Nomura
Hisahiro Matsubara
Makoto Sumazaki
Masaaki Ito
Satoshi Yajima
Hideaki Shimada
Katsuro Iwase
Hiromi Ashino
Hao Wang
Kenichiro Goto
Go Tomiyoshi
Natsuko Shinmen
Rika Nakamura
Hideyuki Kuroda
Yasuo Iwadate
Takaki Hiwasa
author_sort Shu-Yang Li
title Serum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis
title_short Serum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis
title_full Serum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis
title_fullStr Serum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis
title_full_unstemmed Serum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis
title_sort serum anti-ap3d1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/407d11808bd449c58f058a7e82ba8eb4
work_keys_str_mv AT shuyangli serumantiap3d1antibodiesareriskfactorsforacuteischemicstrokerelatedwithatherosclerosis
AT yoichiyoshida serumantiap3d1antibodiesareriskfactorsforacuteischemicstrokerelatedwithatherosclerosis
AT eiichikobayashi serumantiap3d1antibodiesareriskfactorsforacuteischemicstrokerelatedwithatherosclerosis
AT masaakikubota serumantiap3d1antibodiesareriskfactorsforacuteischemicstrokerelatedwithatherosclerosis
AT tomoomatsutani serumantiap3d1antibodiesareriskfactorsforacuteischemicstrokerelatedwithatherosclerosis
AT seiichiromine serumantiap3d1antibodiesareriskfactorsforacuteischemicstrokerelatedwithatherosclerosis
AT toshiomachida serumantiap3d1antibodiesareriskfactorsforacuteischemicstrokerelatedwithatherosclerosis
AT yoshiromaezawa serumantiap3d1antibodiesareriskfactorsforacuteischemicstrokerelatedwithatherosclerosis
AT minorutakemoto serumantiap3d1antibodiesareriskfactorsforacuteischemicstrokerelatedwithatherosclerosis
AT koutaroyokote serumantiap3d1antibodiesareriskfactorsforacuteischemicstrokerelatedwithatherosclerosis
AT yoshiokobayashi serumantiap3d1antibodiesareriskfactorsforacuteischemicstrokerelatedwithatherosclerosis
AT hirotakatakizawa serumantiap3d1antibodiesareriskfactorsforacuteischemicstrokerelatedwithatherosclerosis
AT mizukisata serumantiap3d1antibodiesareriskfactorsforacuteischemicstrokerelatedwithatherosclerosis
AT kazumasayamagishi serumantiap3d1antibodiesareriskfactorsforacuteischemicstrokerelatedwithatherosclerosis
AT hiroyasuiso serumantiap3d1antibodiesareriskfactorsforacuteischemicstrokerelatedwithatherosclerosis
AT noriesawada serumantiap3d1antibodiesareriskfactorsforacuteischemicstrokerelatedwithatherosclerosis
AT shoichirotsugane serumantiap3d1antibodiesareriskfactorsforacuteischemicstrokerelatedwithatherosclerosis
AT soheikobayashi serumantiap3d1antibodiesareriskfactorsforacuteischemicstrokerelatedwithatherosclerosis
AT kazuyukimatsushita serumantiap3d1antibodiesareriskfactorsforacuteischemicstrokerelatedwithatherosclerosis
AT fumionomura serumantiap3d1antibodiesareriskfactorsforacuteischemicstrokerelatedwithatherosclerosis
AT hisahiromatsubara serumantiap3d1antibodiesareriskfactorsforacuteischemicstrokerelatedwithatherosclerosis
AT makotosumazaki serumantiap3d1antibodiesareriskfactorsforacuteischemicstrokerelatedwithatherosclerosis
AT masaakiito serumantiap3d1antibodiesareriskfactorsforacuteischemicstrokerelatedwithatherosclerosis
AT satoshiyajima serumantiap3d1antibodiesareriskfactorsforacuteischemicstrokerelatedwithatherosclerosis
AT hideakishimada serumantiap3d1antibodiesareriskfactorsforacuteischemicstrokerelatedwithatherosclerosis
AT katsuroiwase serumantiap3d1antibodiesareriskfactorsforacuteischemicstrokerelatedwithatherosclerosis
AT hiromiashino serumantiap3d1antibodiesareriskfactorsforacuteischemicstrokerelatedwithatherosclerosis
AT haowang serumantiap3d1antibodiesareriskfactorsforacuteischemicstrokerelatedwithatherosclerosis
AT kenichirogoto serumantiap3d1antibodiesareriskfactorsforacuteischemicstrokerelatedwithatherosclerosis
AT gotomiyoshi serumantiap3d1antibodiesareriskfactorsforacuteischemicstrokerelatedwithatherosclerosis
AT natsukoshinmen serumantiap3d1antibodiesareriskfactorsforacuteischemicstrokerelatedwithatherosclerosis
AT rikanakamura serumantiap3d1antibodiesareriskfactorsforacuteischemicstrokerelatedwithatherosclerosis
AT hideyukikuroda serumantiap3d1antibodiesareriskfactorsforacuteischemicstrokerelatedwithatherosclerosis
AT yasuoiwadate serumantiap3d1antibodiesareriskfactorsforacuteischemicstrokerelatedwithatherosclerosis
AT takakihiwasa serumantiap3d1antibodiesareriskfactorsforacuteischemicstrokerelatedwithatherosclerosis
_version_ 1718391124013350912